General Atlantic LLC Pharvaris N.V. Transaction History
General Atlantic LLC
- $2.83 Billion
- Q3 2025
A detailed history of General Atlantic LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, General Atlantic LLC holds 8,031,252 shares of PHVS stock, worth $189 Million. This represents 7.09% of its overall portfolio holdings.
Number of Shares
8,031,252
Previous 7,531,252
6.64%
Holding current value
$189 Million
Previous $133 Million
51.17%
% of portfolio
7.09%
Previous 4.61%
Shares
5 transactions
Others Institutions Holding PHVS
# of Institutions
82Shares Held
51MCall Options Held
0Put Options Held
0-
Foresite Capital Management Iv, LLC Larkspur, CA4.78MShares$113 Million76.4% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.64MShares$109 Million78.75% of portfolio
-
Viking Global Investors LP3.65MShares$86 Million0.26% of portfolio
-
Eqt Fund Management S.A R.L.3.42MShares$80.6 Million4.59% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.18MShares$74.9 Million25.47% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $795M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...